Last edition
News about "CuraTeQ Biologics"
CuraTeQ Biologics Secures UK MHRA Approval for Bevqolva
Bevqolva 25 mg/mL concentrate for infusion will be available in 4 mL (100 mg) and 16 mL (400 mg) single-use vials for infusion into veins.
CuraTeQ Biologics | 23/12/2024 | By Aishwarya
Aurobindo Pharma Ltd's subsidiary to withdraw application for EU Marketing Authorization of two biosimilars
CuraTeQ Biologics | 26/06/2023 | By Sudeep Soparkar | 487
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members